GLP-1 analogue medicines

This section brings together information and resources about GLP-1 medicines and tirzepatide, including how they work, how they are used in diabetes care, and what to expect when taking them. You’ll find guidance on GLP-1 receptor agonists, oral treatments such as Rybelsus, and information for people who are stopping GLP-1 medicines or tirzepatide. These resources are designed to help you better understand your treatment options and support you in managing your diabetes with confidence.

GLP-1 agonists (also known as GLP-1 analogues, GLP-1 RAs, incretin mimetics and non-insulin injectables)

Mounjaro (Tirzepatide )

Advice for stopping GLP-1 analogs or Tirzepatide (Mounjaro)

When GLP-1 agonists are stopped, it is common to experience increased hunger, changes in blood sugar levels, and possible weight regain. This guidance has been created to help you manage these changes, reduce the risk of weight regain, and maintain stable blood glucose levels after stopping treatment.

GLP-1 analogue medicines

GLP-1 agonists

Rybelsus (Semaglutide)

Tirzepatide (Mounjaro)

Advice for stopping GLP-1 analogs or Tirzepatide (Mounjaro)